120 related articles for article (PubMed ID: 37551499)
1. [Preparation and Application of Monoclonal Antibody Against Human von Willebrand Factor Propeptide].
Yuan JJ; Yin J; Ling J; Shen F; Xie LQ; Bai X; Ruan CG; He Y; Ma ZN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1205-1210. PubMed ID: 37551499
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice.
Jacobi PM; Kanaji S; Jakab D; Gehrand AL; Johnsen JM; Haberichter SL
J Thromb Haemost; 2018 Mar; 16(3):546-554. PubMed ID: 29285851
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
Sanders YV; Groeneveld D; Meijer K; Fijnvandraat K; Cnossen MH; van der Bom JG; Coppens M; de Meris J; Laros-van Gorkom BA; Mauser-Bunschoten EP; Leebeek FW; Eikenboom J;
Blood; 2015 May; 125(19):3006-13. PubMed ID: 25673639
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
[TBL] [Abstract][Full Text] [Related]
5. Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease.
Casonato A; Daidone V; Padrini R
Semin Thromb Hemost; 2011 Jul; 37(5):456-63. PubMed ID: 22102187
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of enhanced von Willebrand factor clearance from plasma.
Seidizadeh O; Baronciani L; Pagliari MT; Cozzi G; Colpani P; Cairo A; Siboni SM; Biguzzi E; Peyvandi F
J Thromb Haemost; 2023 May; 21(5):1112-1122. PubMed ID: 36754679
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor propeptide: biology and clinical utility.
Haberichter SL
Blood; 2015 Oct; 126(15):1753-61. PubMed ID: 26215113
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.
Sztukowska M; Gallinaro L; Cattini MG; Pontara E; Sartorello F; Daidone V; Padrini R; Pagnan A; Casonato A
Br J Haematol; 2008 Oct; 143(1):107-14. PubMed ID: 18691167
[TBL] [Abstract][Full Text] [Related]
10. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
Haberichter SL; Castaman G; Budde U; Peake I; Goodeve A; Rodeghiero F; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill FG; Montgomery RR
Blood; 2008 May; 111(10):4979-85. PubMed ID: 18344424
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
13. Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage.
Haberichter SL; Jacobi P; Montgomery RR
Blood; 2003 Feb; 101(4):1384-91. PubMed ID: 12393513
[TBL] [Abstract][Full Text] [Related]
14. Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.
Lee A; Sinclair G; Valentine K; James P; Poon MC
Blood; 2014 Jul; 124(5):e1-3. PubMed ID: 24951428
[TBL] [Abstract][Full Text] [Related]
15. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Eikenboom J; Federici AB; Dirven RJ; Castaman G; Rodeghiero F; Budde U; Schneppenheim R; Batlle J; Canciani MT; Goudemand J; Peake I; Goodeve A;
Blood; 2013 Mar; 121(12):2336-9. PubMed ID: 23349392
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-mediated in vitro processing of pro-von Willebrand factor.
Váradi K; Turecek PL; Mitterer A; Dorner F; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1449-58. PubMed ID: 11776313
[TBL] [Abstract][Full Text] [Related]
17. The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay.
Meiring SM; Setlai BDP; Theron C; Bragg R
Biomed Res Int; 2018; 2018():6232091. PubMed ID: 29992156
[TBL] [Abstract][Full Text] [Related]
18. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.
Haberichter SL; Balistreri M; Christopherson P; Morateck P; Gavazova S; Bellissimo DB; Manco-Johnson MJ; Gill JC; Montgomery RR
Blood; 2006 Nov; 108(10):3344-51. PubMed ID: 16835381
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
[TBL] [Abstract][Full Text] [Related]
20. [The Effect of VWF Propeptide on VWF Mutant in D1 Domain].
Yu XQ; Ma ZN; Ling J; Zhao YX; Yin J; Yu ZQ; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1541-1548. PubMed ID: 36208263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
